Skip to main content

Marizyme

  • About
      • Back
      • Overview
      • Executive Management
      • Board of Directors
      • Corporate Governance
  • Products
      • Back
      • Overview
      • DuraGraft®
      • Krillase®
      • MATLOC™ Platform
  • Clinical
      • Back
      • Publications
      • DuraGraft Publications
      • MATLOC Publications
  • Investors
  • Contact
      • Back
      • Contact Us
  • Sign Up
  • Language
      • Back
      • GER
adobe stock 229690447 preview

Products
Krillase

  • Overview
  • DuraGraft®
  • Krillase®
  • MATLOC™ Platform

Krillase®

 

group 4531

Krillase is a Krill extract that contains multiple proteolytic enzymes. These enzymes (endo and exopeptidases) rapidly digest and dissolve complex proteinaceous structures, including those that are complexed with organic and inorganic matter and have been shown to be beneficial in the removal of biofilms associated with dental disease, poor wound healing and in the breakdown of arterial plaque and thrombi.

group 4571
Pet Health Market

Products developed using the Krillase technology can be used to reduce plaque accumulation. A Krillase-based product is being developed for the dog dental health market.

  • Bacterial plaque is the most important substrate in the development of periodontal disease.
  • Periodontal disease, most often caused by the accumulation of plaque and poor dental hygiene, has negative consequences on overall health and is one of the most common diseases found in dogs.

group 4573
Market Size

  • Packaged Facts measured the US dog treat market at $7 billion with dental treats being the most widely purchased functional treat.
  • According to Mordor Intelligence, more than 80% of dogs and 70% of cats will develop a type of gum disease by age 3.
  • In the US an estimated 89.7 million dogs are owned costing an annual ~$4.5 billion on dental care alone.
imgfooter

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

 

Investors

  • Back
  • Stock Info
  • SEC Filings
  • Corporate Governance

Contact

  • Back
  • Contact Us
  • Sign Up
 

Get In Touch 

noun map 223137 555 Heritage Drive, Ste. 205,
Jupiter, FL 33458
noun phone 4637987 (561) 935-9955
noun email 3083073 info@marizyme.com 
Marizyme
© Copyright - 2023 Marizyme Inc. | All Rights Reserved | Website by Sandman Media Inc